NCT02558231 The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE3
NCT02525926 Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension Status TERMINATED Phase NA
NCT02484807 Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH Status COMPLETED Phase N/A
NCT02471183 Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE3
NCT02436512 Study to Assess Acute Vasodilation Response of Inhaled Nitric Oxide Status WITHDRAWN Phase PHASE3
NCT02318186 Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase N/A
NCT02310672 REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension Status COMPLETED Phase PHASE4
NCT02309463 Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial Hypertension Status WITHDRAWN Phase N/A
NCT02304198 Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH Status COMPLETED Phase PHASE2/PHASE3
NCT02284737 A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH Status TERMINATED Phase PHASE4
NCT02279745 Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT02279160 Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT02253394 The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study Status TERMINATED Phase PHASE4
NCT02249923 Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry Status RECRUITING Phase N/A
NCT02207868 3D Echo Evaluation of the Ventricles in Sclero Associated Severe PAH Status UNKNOWN Phase N/A